Pine will be responsible for driving operational excellence across the Company’s global business segments and regions Appointment supports Xylem’s continuing commitment to deliver above-market organic revenue growth and margin expansion Pine previously led Xylem’s Americas region and two of Xylem’s global business segments and brings 25 years’ experience in senior and international leadership roles WASHINGTON […]
Quantum-Si combines Time Domain Sequencing™ and Semiconductor Chip Technology to Advance Drug Discovery and Diagnostics and Accelerate Scientific Breakthroughs, Helping People to Live Healthier and Longer Lives Company Appoints Life Science Veteran Grace Johnston, PhD, as Chief Commercial Officer Key Takeaways: The accessibility gained when using Platinum™ is expected to transform science and understanding of the proteome by […]
Key strategic appointment as the Company enters next phase of commercial growth and global expansion of its products and services.Former CEO, Dr David Hughes, appointed to Scientific Advisory Board. CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the appointment of Dr Paul Brooks, formerly the […]
BILLERICA, Mass. — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced that Brian Paras has joined the company as Chief Business Officer. “Brian brings 30-plus years of product introduction & commercialization, global sales & marketing leadership, and key industry partnership & strategic alliance building to the […]
Key appointment forms part of ongoing plans to strengthen senior leadership team and support expansion of microfluidic product range for single cell analysis Cambridge, UK: – Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Richard Hammond as Chief Technical Officer. In his […]
HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Company’s vice president of global finance, as its interim chief financial officer and treasurer, effective upon Mr. Rossi’s resignation. Mr. […]
Next to the company founders, Dr. Wilhelm Kaenders (also Managing Director TOPTICA Photonics AG) and Dr. Frank Lison (Managing Director TOPTICA Projects,) Armin Zach will become responsible for research and technology. TOPTICA Projects has been spun-off from TOPTICA Photonics AG as a separate entity in 2016. Armin Zach has been one of the start-up members […]
INDIANAPOLIS – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023. Moore currently serves as senior vice president, Core Lab and Point of Care, within Roche Diagnostics North America. Moore will succeed and report to Matt Sause, who […]
Rockville, MD — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell–engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announces the appointment of Patrick J. Balthrop, Sr. to the company’s Board of Directors as non-executive director with immediate effect. Mr. Balthrop is also […]
Maravai announces plans for William “Trey” Martin, III to serve as President of its Biologics Safety Testing Segment and its expectation that he will then assume the role of Maravai’s CEO in July 2023 Carl Hull to continue to serve as Executive Chairman and Interim CEO SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
